| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 1 119-127, Copyright © 1996 by American Association of Immunologists
ARTICLES |
JB Splawski, J Nishioka, Y Nishioka and PE Lipsky
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235, USA.
Deficient CD40 ligand (CD40L) expression by neonatal T cells has been proposed to explain the diminished Ig production by newborns. Therefore, we examined the expression and function of CD40L on activated neonatal CD4+ T cells isolated from cord blood. Anti-CD3 activation of neonatal T cells resulted in the expression of CD40L demonstrated with specific mAb or a soluble CD40.G1 construct. The level of expression was comparable to that of adult memory CD4+ T cells. In contrast, PMA and ionomycin induced only minimal CD40L expression by neonatal T cells, whereas adult memory T cells expressed CD40L comparably after stimulation with PMA and ionomycin or anti-CD3. The expression of CD40L was blocked by cyclosporine and prostaglandin E2 (PGE2). IL-2 IL-4 partially reversed the inhibition of CD40L expression by cyclosporine, and IL-2 reversed the inhibition by PGE2. CD40L expressed by neonatal T cells was functionally active, since neonatal T cell-dependent production of IgG4 and IgE was inhibited by a soluble CD40.G1 construct. Moreover, neonatal T cells supported the secretion of significantly more IgG, IgA, and IgE than CD40L-deficient hyper-IgM T cell clones. In addition, neonatal CD4+ T cells induced CD86 B7-2) expression by neonatal B cells that was blocked by anti- CD40L but not by control mAb. The results indicate that neonatal T cells activated through the TCR/CD3 complex express CD40L and use it to promote CD86 expression, Ig secretion and heavy chain isotype switching by neonatal B cells.
This article has been cited by other articles:
|
|
 |
|
  S. Kuchen, R. Robbins, G. P. Sims, C. Sheng, T. M. Phillips, P. E. Lipsky, and R. Ettinger Essential Role of IL-21 in B Cell Activation, Expansion, and Plasma Cell Generation during CD4+ T Cell-B Cell Collaboration J. Immunol., November 1, 2007; 179(9): 5886 - 5896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kaur, S. Chowdhury, N. S. Greenspan, and J. R. Schreiber Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates Blood, October 15, 2007; 110(8): 2948 - 2954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Snyder, J. Shen, H. Azmi, J. Hou, D. H. Fowler, and J. A. Ragheb Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine production Blood, June 15, 2007; 109(12): 5399 - 5406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jullien, R. Q. Cron, K. Dabbagh, A. Cleary, L. Chen, P. Tran, P. Stepick-Biek, and D. B. Lewis Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation Int. Immunol., December 1, 2003; 15(12): 1461 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wingett and C. P. Nielson Divergence in NK cell and cyclic AMP regulation of T cell CD40L expression in asthmatic subjects J. Leukoc. Biol., October 1, 2003; 74(4): 531 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. McDyer, Z. Li, S. John, X. Yu, C.-y. Wu, and J. A. Ragheb IL-2 Receptor Blockade Inhibits Late, But Not Early, IFN-{gamma} and CD40 Ligand Expression in Human T Cells: Disruption of Both IL-12-Dependent and -Independent Pathways of IFN-{gamma} Production J. Immunol., September 1, 2002; 169(5): 2736 - 2746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Matthews, M. Wadhwa, C. Bird, F. E. Borras, and C. V. Navarrete Sustained Expression of CD154 (CD40L) and Proinflammatory Cytokine Production by Alloantigen-Stimulated Umbilical Cord Blood T Cells J. Immunol., June 15, 2000; 164(12): 6206 - 6212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Samten, E. K. Thomas, J. Gong, and P. F. Barnes Depressed CD40 Ligand Expression Contributes to Reduced Gamma Interferon Production in Human Tuberculosis Infect. Immun., May 1, 2000; 68(5): 3002 - 3006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ottendorfer, T. M. Ellis, K. S. Bahjat, M. Clare-Salzler, and M. A. Atkinson No Alteration in T Lymphocyte Expression of CD40 Ligand (CD154) in Individuals with or at Increased Risk for Insulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4068 - 4072. [Abstract] [Full Text]
|
|
|
|
|
|
A. C. Grammer, R. D. McFarland, J. Heaney, B. F. Darnell, and P. E. Lipsky Expression, Regulation, and Function of B Cell-Expressed CD154 in Germinal Centers J. Immunol., October 15, 1999; 163(8): 4150 - 4159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E Donovan and P. W Finn Immune mechanisms of childhood asthma Thorax, October 1, 1999; 54(10): 938 - 946. [Full Text]
|
|
|
|
|
|
M. Astori, D. Finke, O. Karapetian, and H. Acha-Orbea Development of T–B cell collaboration in neonatal mice Int. Immunol., March 1, 1999; 11(3): 445 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wykes, A. Pombo, C. Jenkins, and G. G. MacPherson Dendritic Cells Interact Directly with Naive B Lymphocytes to Transfer Antigen and Initiate Class Switching in a Primary T-Dependent Response J. Immunol., August 1, 1998; 161(3): 1313 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Flamand, V. Donckier, F.-X. Demoor, A. Le Moine, P. Matthys, M.-L. Vanderhaeghen, Y.-i. Tagawa, Y. Iwakura, A. Billiau, D. Abramowicz, et al. Cutting Edge: CD40 Ligation Prevents Neonatal Induction of Transplantation Tolerance J. Immunol., May 15, 1998; 160(10): 4666 - 4669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Porcu, J. Gaddy, and H. E. Broxmeyer Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras PNAS, April 14, 1998; 95(8): 4538 - 4543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Peng, J. E. Remacle, A. Kasran, D. Huylebroeck, and J. L. Ceuppens IL-12 Up-Regulates CD40 Ligand (CD154) Expression on Human T Cells J. Immunol., February 1, 1998; 160(3): 1166 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Balashov, D. R. Smith, S. J. Khoury, D. A. Hafler, and H. L. Weiner Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand PNAS, January 21, 1997; 94(2): 599 - 603. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
